d2,s5,s3-expansion of biowaivers and global development of generic products
Published 2 years ago • 113 plays • Length 15:05
Download video MP4
Download video MP3
Similar videos
-
17:31
d2,s5,s7-how can scientific advancements help align global development of complex generic products?
-
19:04
d2,s5,s6-challenges and opportunities for global development
-
7:53
d2,s5,s1-current challenges to complex generic drug development under divergent global regulations
-
15:05
d2,s6,s5-implementing gdufa science in product development & andas: realizations & recommendations
-
17:59
product development considerations for generic topical products (22of39) complex generics 2018
-
10:06
d2,s6,s3-research needs to accelerate product-specific guidance development for complex products
-
1:57:52
complex generics: topical products, part 1
-
19:10
product-specific guidances for complex generic drugs
-
21:09
in vitro release testing for complex generics: a bioequivalence perspective
-
1:31:52
complex generics: topical products, part 2
-
23:51
bioequivalence for generic topical and transdermal (6of35) complex generics– sep. 25-26, 2019
-
1:59:34
cutting edge science in complex generics
-
2:09
bio-shield don 5 and bio-shield fumonisin 5 usda/fgis approval
-
11:49
ivdr tutorial for diagnostic labs 5: preparatory action 2: assay inventory
-
3:11
regulatory requirements for bioequivalence & biowaiver studies
-
2:01
5-ethynyl-2'-deoxyuridine/phospho-histone h3 dual-labeling l protocol preview
-
19:19
biopharmaceutics classification system class 3 waiver
-
14:36
d2,s6,s1-from the bench to approval: the role of gdufa research in promoting complex generics
-
12:45
alternative pathway of complement activation
Clip.africa.com - Privacy-policy